Oncopole Claudius Regaud
Toulouse, Haute-garonne 31059
1 studies enrolling now · 2 studies all time
What they study most
Metastatic Castrate Resistant Prostate Cancer (mCRPC), Metastatic Castration-resistant Prostate Cancer
Studies at this site
- A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer — Recruiting now
- A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1). — Running, not enrolling